Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating plasma proteomics with genome-wide association data to identify novel drug targets for inflammatory bowel disease. | Sci Rep | 2024 | 39009667 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| Pyridopyrimidinones as a new chemotype of calcium dependent protein kinase 1 (CDPK1) inhibitors for Cryptosporidium. | Mol Biochem Parasitol | 2024 | 38901801 | PubTator, text mining | PubMed |
| A novel model for relation prediction in knowledge graphs exploiting semantic and structural feature integration. | Sci Rep | 2024 | 38839794 | PubTator, text mining | PubMed |
| Expression of Truncated Products at the 5'-Terminal Region of RIPK2 and Evolutive Aspects that Support Their Biological Importance. | Genome Biol Evol | 2024 | 38752399 | PubTator, text mining | PubMed |
| An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer. | Front Immunol | 2024 | 38742117 | PubTator, text mining | PubMed |
| Pharmacological inhibition of receptor-interacting protein kinase 2 (RIPK2) elicits neuroprotective effects following experimental ischemic stroke. | Exp Neurol | 2024 | 38729551 | PubTator, text mining | PubMed |
| Novel immune cross-talk between inflammatory bowel disease and IgA nephropathy. | Ren Fail | 2024 | 38628140 | PubTator, text mining | PubMed |
Correction for Huang et al., "Chemotherapeutic Drugs Induce Different Gut Microbiota Disorder Pattern and NOD/RIP2/NF-κB Signaling Pathway Activation That Lead to Different Degrees of Intestinal Injury". | Microbiol Spectr | 2024 | 38529960 | PubTator, text mining | PubMed |
| Harnessing innate immune pathways for therapeutic advancement in cancer. | Signal Transduct Target Ther | 2024 | 38523155 | PubTator, text mining | PubMed |
| Crosstalk between NOD2 and TLR2 suppresses the development of TLR2-mediated experimental colitis. | J Clin Biochem Nutr | 2024 | 38510686 | PubTator, text mining | PubMed |
| Identifying functional dysregulation of NOD2 variant Q902K in patients with Yao syndrome. | Arthritis Res Ther | 2024 | 38395960 | PubTator, text mining | PubMed |
| Ripks and Neuroinflammation. | Mol Neurobiol | 2024 | 38349514 | PubTator, text mining | PubMed |
| "RIPping" off Pancreas Cancer's Blockage of Immune Surveillance. | Cancer Discov | 2024 | 38327192 | PubTator, text mining | PubMed |
| MIF modulates p38/ERK phosphorylation via MKP-1 induction in sarcoidosis. | iScience | 2024 | 38299032 | PubTator, text mining | PubMed |
| Synchronous functional magnetic resonance eye imaging, video ophthalmoscopy, and eye surface imaging reveal the human brain and eye pulsation mechanisms. | Sci Rep | 2024 | 38278832 | PubTator, text mining | PubMed |
| Novel role of peptidoglycan recognition protein 2 in activating NOD2-NFκB inflammatory axis in coronary artery disease. | Atherosclerosis | 2024 | 38277990 | PubTator, text mining | PubMed |
| The Role of the Gut Microbiome in the Development of Acute Pancreatitis. | Int J Mol Sci | 2024 | 38256232 | PubTator, text mining | PubMed |
| Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy Cancer Patients. | Int J Mol Sci | 2024 | 38256152 | PubTator, text mining | PubMed |
| RhoGDI phosphorylation by PKC promotes its interaction with death receptor p75NTR to gate axon growth and neuron survival. | EMBO Rep | 2024 | 38253689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=7